相关实验视频
Updated: Jun 21, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
储存的血小板静止表型和功能不会在供体接受替代疗法时发生变化
Alisha Chitrakar1, Scott-Wesley M Bean1, Tamir Kanias1,2
1Vitalant Research Institute, Denver, Colorado, USA.
来自替代疗法 (TRT) 供体的血小板与对照供体的血小板具有类似的功能和表型. 这表明TRT捐赠者可能是血小板产品的可行来源,解决血液供应短缺问题.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
- 内分泌学 在内分泌学.
背景情况:
- 全国血液供应面临严重短缺,这促使人们探索替代捐献来源.
- 来自替代疗法 (TRT) 捐赠者的红细胞有条件被批准用于输血.
- 来自TRT捐献者的血小板由于安全性和功能数据有限而未得到批准.
研究的目的:
- 与对照组相比,从TRT捐献者的血小板的表型和功能进行全面分析.
- 评估超生理对输血相关的血小板特征的影响.
主要方法:
- 从TRT和对照捐赠者收集的血小板 (N=10/组,年龄/性别匹配).
- 在7天的储存时间内分析了血小板数,代谢参数,表面受体,聚合,血栓生成和血栓形成.
- 对两组的D1和D7结果进行比较.
主要成果:
- TRT供体血小板在计数,表型,新陈代谢,聚合或血栓生成方面与对照没有显著差异.
- 这两组在第7天表现出血静功能减少,相比于第1天.
- 在动脉流量条件下,血栓形成没有显著差异.
结论:
- 来自TRT供体的血小板具有类似的表型和功能配置文件来控制供体血小板.
- 对TRT捐献者的治疗性瘤切除是血小板产品的潜在来源.
- 进一步的研究可能会支持使用TRT衍生的血小板来缓解血液短缺.
更多相关视频
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Testosterone: Functions and Regulation
Clot Retraction and Fibrinolysis
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...